Clinical Trial Update: Study to Evaluate the Safety and Immunogenicity of MEDI-517P in Healthy Adult Female Volunteers Who Are HPV-16 or HPV-18 DNA Positive [Phase 1, Phase 2]

View source ↗

Summary

Completed Phase 1/2 clinical trial evaluating the safety and immunogenicity of the HPV vaccine candidate MEDI-517P in healthy adult female volunteers who are HP…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cervical Cancer
• Human Papillomavirus Infection

Drugs mentioned

• MEDI-517P

Snippet

Sponsor: MedImmune LLC | Conditions: Healthy | Phase 1, Phase 2 | Status: COMPLETED